Efficiency of Protective Interventions on Irinotecan-Induced Diarrhea: A Systematic Review and Meta-Analysis

IF 2.9 3区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE
Yanxi He, Lili Wu, Xiaoyi Qi, Xuan Wang, Bing He, Wei Zhang, Wenjing Zhao, Mingming Deng, Xia Xiong, Yu Wang, Sicheng Liang
{"title":"Efficiency of Protective Interventions on Irinotecan-Induced Diarrhea: A Systematic Review and Meta-Analysis","authors":"Yanxi He, Lili Wu, Xiaoyi Qi, Xuan Wang, Bing He, Wei Zhang, Wenjing Zhao, Mingming Deng, Xia Xiong, Yu Wang, Sicheng Liang","doi":"10.1177/15347354241242110","DOIUrl":null,"url":null,"abstract":"Background:Irinotecan is widely used in the treatment of various solid tumors, but the adverse effects from it, especially diarrhea, limit its use. Several clinical trials of prophylactic treatment of irinotecan-induced diarrhea (IID) have been ongoing, and some of the data are controversial. This encouraged us to conduct a meta-analysis of the effects of interventions on preventing IID.Method:This systematic review was conducted based on the PRISMA statement. We performed literature searches from PubMed, Web of Science, Embase, and Cochrane Library. The number registered in PROSPERO is CRD42022368633. After searching 1034 articles in the database and references, 8 studies were included in this meta-analysis.Result:The RR of high-grade diarrhea and all-grade diarrhea were 0.31 ( I<jats:sup>2</jats:sup> = 51%, 95% CI: 0.14-0.69; P = .004) and .76 ( I<jats:sup>2</jats:sup> = 65%, 95% CI: 0.62-0.93; P &lt; .008) respectively, thus the use of intervention measures for preventing IID is effective, and the risk reduction of high-grade diarrhea was more significant. Subgroup analysis revealed that the monotherapy group (RR: 0.48, 95% CI: 0.21-1.13, I<jats:sup>2</jats:sup> = 0%) and combination therapy group (RR: 0.14, 95% CI: 0.06-0.32, I<jats:sup>2</jats:sup> = 0%) in the risk of high-grade diarrhea had no significant heterogeneity within the groups, and traditional herbal medicines (Kampo medicine Hangeshashin-to, PHY906 and hot ironing with Moxa Salt Packet on Tianshu and Shangjuxu) were effective preventive measures (RR:0.20, 95% CI: 0.07-0.60, I<jats:sup>2</jats:sup> = 0%). The Jadad scores for traditional herbal medicines studies were 3, and the follow-up duration was only 2 to 6 weeks.Conclusion:This systematic review and meta-analysis suggest that preventive treatments significantly reduced the risk of high-grade and all-grade diarrhea, confirming the efficacy in the incidence and severity of IID, among which traditional herbal medicines (baicalin-containing) provided a protective effect in reducing the severity of IID. However, the traditional herbal medicines studies were of low quality. Combined irinotecan therapy can obtain better preventive effects than monotherapy of IID. These would be helpful for the prevention of IID in clinical practice.","PeriodicalId":13734,"journal":{"name":"Integrative Cancer Therapies","volume":"63 1","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2024-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Integrative Cancer Therapies","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15347354241242110","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Background:Irinotecan is widely used in the treatment of various solid tumors, but the adverse effects from it, especially diarrhea, limit its use. Several clinical trials of prophylactic treatment of irinotecan-induced diarrhea (IID) have been ongoing, and some of the data are controversial. This encouraged us to conduct a meta-analysis of the effects of interventions on preventing IID.Method:This systematic review was conducted based on the PRISMA statement. We performed literature searches from PubMed, Web of Science, Embase, and Cochrane Library. The number registered in PROSPERO is CRD42022368633. After searching 1034 articles in the database and references, 8 studies were included in this meta-analysis.Result:The RR of high-grade diarrhea and all-grade diarrhea were 0.31 ( I2 = 51%, 95% CI: 0.14-0.69; P = .004) and .76 ( I2 = 65%, 95% CI: 0.62-0.93; P < .008) respectively, thus the use of intervention measures for preventing IID is effective, and the risk reduction of high-grade diarrhea was more significant. Subgroup analysis revealed that the monotherapy group (RR: 0.48, 95% CI: 0.21-1.13, I2 = 0%) and combination therapy group (RR: 0.14, 95% CI: 0.06-0.32, I2 = 0%) in the risk of high-grade diarrhea had no significant heterogeneity within the groups, and traditional herbal medicines (Kampo medicine Hangeshashin-to, PHY906 and hot ironing with Moxa Salt Packet on Tianshu and Shangjuxu) were effective preventive measures (RR:0.20, 95% CI: 0.07-0.60, I2 = 0%). The Jadad scores for traditional herbal medicines studies were 3, and the follow-up duration was only 2 to 6 weeks.Conclusion:This systematic review and meta-analysis suggest that preventive treatments significantly reduced the risk of high-grade and all-grade diarrhea, confirming the efficacy in the incidence and severity of IID, among which traditional herbal medicines (baicalin-containing) provided a protective effect in reducing the severity of IID. However, the traditional herbal medicines studies were of low quality. Combined irinotecan therapy can obtain better preventive effects than monotherapy of IID. These would be helpful for the prevention of IID in clinical practice.
伊立替康诱发腹泻的保护性干预措施的效率:系统回顾与元分析
背景:伊立替康被广泛用于各种实体瘤的治疗,但其不良反应,尤其是腹泻,限制了其使用。针对伊立替康诱发腹泻(IID)的预防性治疗的几项临床试验一直在进行中,其中一些数据存在争议。这促使我们对预防 IID 的干预效果进行荟萃分析。我们在 PubMed、Web of Science、Embase 和 Cochrane 图书馆进行了文献检索。在 PROSPERO 中注册的编号为 CRD42022368633。结果:高分级腹泻和全分级腹泻的RR分别为0.31 ( I2 = 51%, 95% CI: 0.14-0.69; P = .004) 和0.76 ( I2 = 65%, 95% CI: 0.62-0.93; P <.008),因此使用干预措施预防IID是有效的,且高分级腹泻的风险降低更为显著。亚组分析显示,单药治疗组(RR:0.48,95% CI:0.21-1.13,I2 = 0%)和联合治疗组(RR:0.14,95% CI:0.06-0.32,I2 = 0%)的高级别腹泻风险在组内无显著异质性,传统中药(康普药杭夏心妥、PHY906和天枢、上巨虚艾盐包热熨)是有效的预防措施(RR:0.20,95% CI:0.07-0.60,I2 = 0%)。结论:该系统综述和荟萃分析表明,预防性治疗可显著降低高级别和全级别腹泻的风险,证实其对 IID 的发病率和严重程度具有疗效,其中传统中药(含黄芩苷)对降低 IID 的严重程度具有保护作用。然而,传统草药研究的质量较低。联合伊立替康疗法比单一伊立替康疗法具有更好的预防效果。这将有助于在临床实践中预防 IID。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Integrative Cancer Therapies
Integrative Cancer Therapies 医学-全科医学与补充医学
CiteScore
4.80
自引率
3.40%
发文量
78
审稿时长
>12 weeks
期刊介绍: ICT is the first journal to spearhead and focus on a new and growing movement in cancer treatment. The journal emphasizes scientific understanding of alternative medicine and traditional medicine therapies, and their responsible integration with conventional health care. Integrative care includes therapeutic interventions in diet, lifestyle, exercise, stress care, and nutritional supplements, as well as experimental vaccines, chrono-chemotherapy, and other advanced treatments. Contributors are leading oncologists, researchers, nurses, and health-care professionals.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信